The mango (Mangifera indica) is among the most widely consumed fruits globally. It is the third-largest agricultural product in India, and approximately 2.26 million acres (40% of the total area) are used for mango cultivation. However, overconsumption and processing of mangoes lead to increased waste generation, causing chronic environmental problems. Around 35 to 60% of the mango fruit, such as seed, peel and seed husk wastes, are generated during industrial processing of mango. Mango byproducts are considered a low-cost source of bioactive compounds and nutrients. These essential constituents, such as fiber, proteins, lipids, carbohydrates, vitamins, polyphenols, antioxidants, flavonoids, tannins and xanthones, anthocyanins, carotenoids, etc., are discussed thoroughly in this article. Phytoconstituents present in these byproducts are responsible for various therapeutic activities, including anticancer, anti-inflammatory, and antidiabetic properties. These byproducts are employed in various pharmaceutical and cosmeceutical sectors as emulsions, hydrogels, ointments, hydrocolloids, creams, gel beads, non-structured lipid carriers (NLCs), body scrubs, toothpastes, and lipsticks, as a step towards valorizing increasing mango waste production. The existing literature indicates that no standardized process for extracting bioactive compounds from plant tissues has yet been developed. This review provided extensive information on valorization of mango by-products, i.e., seed and peel, in the pharmaceutical and cosmeceutical fields, including the details of the extraction process, patents, and marketed as well as toxicology reports are highlighted.
Baruah et al. (Sun,) studied this question.